Vesalius Biocapital related stories
All articles and analysis
Amakem Seals $25.3M Series AForbion Capital Partners has led an 18 million euro ($25.3 million) Series A round for Belgium-based Amakem NV. Crédit Agricole Private Equity, Vesalius BioCapital, as well as the existing investors LRM, PMV and Life Sciences Research Partners also contributed to the round. Amakem will use the money to expand its ophthalmology drug development portfolio, the company said.
- Belgium-based Complix Raises €5 Million
Complix NV, a Belgium-based developer of "alphabodies" for autoimmune and infectious diseases, has raised €5 million in Series A funding. Backers include Vesalius Biocapital, LRM and CRP Santé.
- peHUB Wire: Monday, November 9, 2009
Random Ramblings
- peHUB Wire: Monday, November 9, 2009
Random Ramblings
- Promethera Biosciences Raises €5.3 Million
Promethera Biosciences, a Belgium-based stem cell therapy company, has raised €5.3 million in new Series A funding. Vesalius Biocapital led the round, and was joined by SRIW, Life Sciences Research Partners, NivelInvest, Capital & Croissance, LRM Oxygen for Growth, Vives and return backer Sopartec.
- Activaero Raises €10.7 Million
Activaero GmbH, a German developer of controlled breathing devices for inhaled therapeutic agents, has raised €10.7 million in Series A funding. BioMedPartners led the round, and was joined by VI Partners, Abalis Finance AG and Vesalius Biocapital. MedVenture Partners served as placement agent.
- peHUB Wire: Thursday, October 29, 2009
Random Ramblings
- peHUB Wire: Thursday, October 29, 2009
Random Ramblings